Antidepressants in Pregnancy and Breastfeeding: Planning Care

Evidence checked 2026-09-24 · 6.9772727272727 min read

Updated 24 September 2026. General educational information, not an individualized pregnancy, prescribing or infant-feeding recommendation.

Compare realistic options, not treatment with a risk-free alternative

Every decision occurs in a particular clinical situation. Continuing a medicine, changing it, using psychological treatment and stopping each have possible benefits and disadvantages. Untreated or inadequately treated depression can affect wellbeing, functioning and access to care. That is relevant without making someone responsible for every possible pregnancy outcome.

The American College of Obstetricians and Gynecologists recommends discussing depression treatment during pregnancy with a health professional. Ask how your history changes the comparison rather than applying another person’s decision to yourself. A severe previous episode may lead to different advice from a brief, mild episode with sustained recovery.

Preconception planning can reduce rushed decisions

When possible, arrange a review before trying to conceive. Bring the medication name, formulation, prescribed schedule, duration of use and previous treatment experiences. Include what happened after earlier dose changes or attempts to stop, especially a relapse or difficult withdrawal.

Ask which clinician will coordinate the plan and when it should be reviewed. A useful discussion includes treatment access, maternity appointments, sleep and practical support after birth. You do not need to solve every uncertainty before becoming pregnant, but documenting the main decisions can reduce contradictory advice later.

What to do after an unexpected positive test

Contact the prescriber and maternity service promptly to arrange advice, but do not independently stop or halve the prescription. An abrupt change can create withdrawal or destabilize an illness. The next step depends on the medicine, health history and stage of pregnancy.

Write down when you learned about the pregnancy and the medicines already taken, including supplements and occasional products. Avoid repeatedly searching for worst-case outcomes before speaking with a professional. A pregnancy exposure does not by itself prove that harm occurred, and a change made in panic may not improve the balance of care.

Why the exact medicine matters

Antidepressants are not interchangeable in pregnancy evidence, interactions or previous effectiveness. Some have more published information than others. Evidence about one SSRI does not automatically answer a question about bupropion, mirtazapine or an SNRI.

The UK Teratology Information Service’s BUMPS sertraline leaflet illustrates the kind of medicine-specific discussion available. Ask the clinician to use the information relevant to your actual prescription. Do not assume that a brand described as preferred for someone starting treatment must replace a medicine that has kept you well.

Interpret risk numbers carefully

Ask for absolute numbers when a risk is described as increased. A relative percentage does not show how common an outcome is to begin with. Also ask whether a study can separate the effect of medication from depression severity, other illness, smoking or other differences between groups.

This does not mean all research can be dismissed. It means uncertainty should be explained without turning an association into a certainty about your baby. Request a written summary of the most relevant findings and what, if anything, they change in your care plan.

Continuing a successful treatment versus switching

Switching can introduce a new medicine, a period of uncertain response and potential withdrawal from the previous one. Continuing also requires review of benefits and precautions. The decision should consider whether there is a clear clinical reason to change, not simply whether another drug appears first on an internet list.

The NICE antenatal and postnatal mental-health guideline emphasizes informed decisions that include previous response and the risks of changing treatment. Ask how a proposed switch would be monitored and what would happen if symptoms returned. Never construct a cross-taper yourself.

Psychological treatment can be part of the plan

Appropriate psychological care may be used alone or alongside medication, depending on the assessment. It should address the actual problem, such as depressive withdrawal, anxiety or relationship difficulties, rather than implying that positive thinking removes all pregnancy concerns.

Discuss access, session format and practical barriers before assuming therapy is available as an immediate replacement. A waiting list still requires an interim support plan. Our therapy guides explain several approaches, and prenatal depression covers assessment beyond medication decisions.

Review symptoms throughout pregnancy

A plan agreed early in pregnancy may need revisiting as health, symptoms or circumstances change. Report worsening depression, difficulty eating, severe sleep disruption or problems taking the prescribed medicine. Do not independently adjust doses because you assume pregnancy always requires less or more medication.

Track a few meaningful indicators, such as attending appointments, maintaining food intake and managing essential daily tasks. If nausea prevents taking medicine or keeping it down, ask the pharmacist or prescriber what to do. Do not repeat a dose automatically when uncertain how much was absorbed.

Planning for birth and newborn observation

Tell the maternity team about medication used later in pregnancy. Some antidepressant exposures can be associated with temporary adaptation symptoms after birth, and clinicians may recommend observation according to the medicine and circumstances. A newborn symptom still requires assessment rather than an assumption that medication explains everything.

The MHRA safety advice also describes a small increased postpartum bleeding risk with late-pregnancy SSRI or SNRI use. This supports informed obstetric planning, not an instruction to stop treatment shortly before delivery without advice.

Breastfeeding decisions are individualized too

Medicine transfer into milk varies, and the infant’s health matters. A recommendation for a healthy full-term baby may not apply to a premature or medically unwell infant. Ask the maternity, prescribing and infant-care teams to coordinate rather than leaving you to reconcile conflicting general statements.

The NHS Specialist Pharmacy Service SSRI guidance often favors sertraline or paroxetine when an SSRI is being selected for breastfeeding. It also states that an effective pregnancy SSRI does not necessarily need changing solely for breastfeeding when the infant is healthy and full term.

Other antidepressants and feeding choices

Advice differs for other medicines and combinations. The Specialist Pharmacy Service information on other antidepressants discusses mirtazapine, duloxetine, venlafaxine and trazodone with attention to infant monitoring and treatment continuity. It does not justify a blanket rule that every non-SSRI must be stopped.

Breastfeeding, formula feeding or mixed feeding may each be part of an individualized plan. Do not allow pressure about feeding to prevent effective depression care. Ask for practical support and clear medicine-specific advice instead of assuming that skipping doses around feeds makes exposure predictably safe.

Agree what to watch for in the infant

Ask the baby’s clinician which signs warrant contact, such as unusual drowsiness, difficulty waking to feed, poor feeding or concerns about growth. Monitoring should fit the actual medicine and infant, not involve anxiously checking every normal movement.

Breathing difficulty, marked unresponsiveness or another serious change requires urgent assessment. Tell the clinician about pregnancy and breastfeeding exposures, but do not delay care while deciding whether the medicine is the cause. A feeding problem can have several explanations that deserve appropriate evaluation.

Sedation, sleep and practical safety

Discuss nighttime caregiving when a medicine makes you sleepy. Specialist breastfeeding guidance advises avoiding bed-sharing with an infant after sedating medication. Ask the maternity team for a safe sleep plan suited to your situation and arrange practical help when you are too impaired to provide care safely.

Protecting sleep is also a mental-health consideration. Agree how another adult can help with essential tasks without assuming that one feeding arrangement automatically solves the problem. A plan should account for recovery after birth, other children and the limits of the support actually available.

Recognizing a postpartum mental-health emergency

Severe confusion, hallucinations, unusual fixed beliefs or markedly increased energy with very little need for sleep after birth requires urgent medical assessment. These symptoms should not be dismissed as ordinary sleep deprivation or handled only by adjusting an antidepressant.

Our postpartum psychosis guide explains this emergency distinction. Suicidal thoughts or concern about safely caring for yourself or the baby also deserves prompt support. Immediate danger requires emergency services; do not wait for a routine postnatal check.

Make the handover explicit

Before leaving maternity care, confirm who will issue prescriptions, review mood and discuss infant monitoring. Include contact details for deterioration and the date of the next appointment. A plan should remain clear if one clinician is unavailable.

Keep a concise copy with the medicine list and previous treatment response. Ask for an interpreter or written explanation when needed. Your role is not to become the sole expert in pregnancy pharmacology; the clinical team should help make the decision understandable and workable.

Frequently asked questions

Should I stop as soon as pregnancy is confirmed?

No automatic rule applies. Obtain prompt professional advice and avoid abrupt, unsupervised changes.

Does preferred during breastfeeding mean safest for every pregnancy?

No. Pregnancy and breastfeeding involve different evidence and circumstances. Prior response and the infant’s health also matter.

Can I receive treatment while uncertain about feeding?

Yes. Discuss the uncertainty openly so that mental-health treatment and feeding support can be planned together rather than making one a condition of the other.